After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?

Albemarle released its second-quarter earnings report on Aug. 5. Here’s Morningstar’s take on Albemarle’s earnings and stock.

Key Morningstar Metrics for Albemarle

• Fair Value Estimate
  : $200.00
• Morningstar Rating
  : ★★★★
• Morningstar Economic Moat Rating
  : Narrow
• Morningstar Uncertainty Rating
  : Very High

What We Thought of Albemarle’s Q2 Earnings

Albemarle reported strong second-quarter results, as higher lithium prices drove more than 150% profit growth year over year.

Why it matters: Albemarle shares were up 8% on Aug. 6 as the market reacted to the results. Management does not guide to profits, so the market tends to use the most recent results and lithium spot and futures prices as directional indicators of profits.

• The huge profit increase is in line with our view that Albemarle’s low-cost lithium operations, which underpin our narrow-moat rating, will allow the company to generate strong profits and positive free cash flow.
• Albemarle should benefit from rising long-term lithium demand from growing global electric vehicle sales and the buildout of utility-scale energy storage batteries. We view low-cost lithium producers as “picks and shovels” winners of the EV and ESS growth.

The bottom line: We maintain our $200 fair value estimate for narrow-moat Albemarle. We forecast Albemarle will continue to generate strong profits in 2026 and beyond, buoyed by lithium prices around midcycle levels.

• Lithium spot prices have fluctuated but averaged $20,000 per metric ton so far in 2026. This is in line with our long-term forecast based on the marginal cost of production. At this level, Albemarle’s low-cost lithium operations should continue to generate current profits.
• We view Albemarle shares as significantly undervalued, trading around 40% below our fair value estimate. We think the market is worried CATL’s lithium mine restarts will drive oversupply and lower prices. But we see growing demand keeping the market in balance.

The following are excerpts from Morningstar’s company report on Albemarle.

Fair Value Estimate for Albemarle

With its 4-star rating, we believe Albemarle’s stock is moderately undervalued compared with our long-term fair value estimate of $200. We assume a roughly 10% weighted-average cost of capital. Lithium will remain Albemarle’s largest business. As its demand growth remains strong and global supply growth slows, we expect the market to remain closer to balance in 2026. We forecast that specialties (bromine and nonbattery lithium) will see higher profits in 2026 due to Iran-war-related supply shock to bromine, benefiting Albemarle’s US operation.

Read more about Albemarle’s fair value estimate.

Economic Moat Rating

We award a narrow economic moat rating to Albemarle for its strong and durable cost advantage in lithium and bromine production. Albemarle has a cost advantage in lithium carbonate production due to its lucrative brine assets in the Salar de Atacama in Chile, which produce lithium at the lowest cost globally, excluding royalties. Albemarle’s advantaged position in bromine comes from its low-cost and long-lived assets in the Dead Sea and Arkansas. In all, we think Albemarle’s strong and durable cost advantage in lithium and bromine makes it more likely than not that the company will outearn its cost of capital over at least the next decade.

Read more about Albemarle’s economic moat.

Financial Strength

Albemarle is currently in good financial health. As of the end of the second quarter, management reported net debt/adjusted EBITDA was 0.5 times, well below its long-term target of less than 2.5. We expect adjusted EBITDA and free cash flow to rise substantially in 2026 due to higher lithium prices. Management plans to use some of the free cash flow to pay down debt. Following low lithium prices in 2025, Albemarle plans to keep capital expenditures low in 2026 and to pursue more measured growth. This should result in Albemarle maintaining its good financial health. Additionally, Albemarle will divest a 51% stake in Ketjen, its catalysts business, to KPS for $660 million before taxes and fees, with the deal expected to close in 2026. These funds should also bolster the balance sheet.

Read more about Albemarle’s financial strength.

Risk and Uncertainty

We assign Albemarle a Very High Uncertainty Rating. The biggest risk for Albemarle is volatile lithium prices. Prices could decline if demand grows more slowly than expected due to slowing EV sales growth. New batteries, such as sodium-ion, could overtake lithium as the preferred energy storage resource. New lithium production technologies could also alter the cost curve.

Albemarle faces execution risk in ramping up its new lithium projects, including production delays and cost overruns. Albemarle is also subject to political risk in Chile. President Gabriel Boric wants the Chilean government to own a majority stake in all projects. If this occurs, Albemarle could be forced to trade a 50.1% stake to the Chilean government to extend its lease when it expires in 2043.

The largest ESG risks come from potential new regulations. Regulations could limit emissions in the bromine business, and the company may not be able to pass along the cost increases. We see this as having a moderate probability and materiality. Another risk is that Albemarle may have its products banned due to their environmental impact, which has occurred before in the bromine business. We see a moderate probability but a low materiality, as Albemarle doesn’t rely on a single product and could modify its products to meet new regulations, similar to what occurred when products have been banned.

Read more about Albemarle’s risk and uncertainty.

ALB Bulls Say

• Albemarle has top-tier lithium assets through its brine operations in Chile and spodumene hard-rock operations in Western Australia, which are among the lowest-cost sources of lithium production globally.
• Lithium prices will rebound and then remain well above the marginal cost of production through at least the remainder of the decade, leading to excess profits and return on invested capital for Albemarle.
• Albemarle has low-cost bromine production through its highly concentrated brines in the Dead Sea and Arkansas.

ALB Bears Say

• Lithium prices will fall and remain lower for longer as new supply growth will outpace demand, weighing on profitability.
• Albemarle’s investment in higher-cost lithium resources, including Wogdina and King’s Mountain, will prove value-destructive as they will not generate returns above its weighted average cost of capital.
• Chile’s plan to nationalize lithium could result in Albemarle being forced to trade a majority stake to the government to renew its lease, destroying shareholder value.

This article was compiled by Irza Waraich.